These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 28941362

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severity.
    Naveau S, Emilie D, Balian A, Grangeot-Keros L, Borotto E, Portier A, Giraud V, Capron F, Galanaud P, Chaput JC.
    J Hepatol; 1998 May; 28(5):778-84. PubMed ID: 9625312
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serum levels of intercellular adhesion molecule-1 in patients with alcoholic liver disease.
    Shimada S, Yamauchi M, Toda G.
    Alcohol Alcohol Suppl; 1993 May; 1B():47-51. PubMed ID: 7911670
    [Abstract] [Full Text] [Related]

  • 6. Plasma protein C as a marker of hepatocellular damage in alcoholic liver disease.
    Kłoczko J, Mian M, Wojtukiewicz MZ, Babiuch L, Bielawiec M, Galar M.
    Haemostasis; 1992 May; 22(6):340-4. PubMed ID: 1362178
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
    Grimbert S, Trinchet JC, Hartmann DJ, Munz C, Garnier M, Mal F, Callard P, Beaugrand M.
    Gastroenterol Clin Biol; 1993 May; 17(8-9):570-7. PubMed ID: 8253314
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of lymphocyte cytotoxicity by serum from patients with alcoholic liver disease: partial characterization of serum inhibitors.
    Wands JR, Dienstag JL.
    Yale J Biol Med; 1978 May; 51(6):615-23. PubMed ID: 313125
    [Abstract] [Full Text] [Related]

  • 11. [Measurement of serum type III procollagen aminopeptide with RIA-gnost PIIIP coated tube: changes in patients with various alcoholic liver diseases after abstinence].
    Maruyama K, Okazaki I, Takagi T, Takahashi H, Okuyama K, Horie Y, Takagi S, Kohno H, Sato S, Ishii H.
    Kaku Igaku; 1992 Feb; 29(2):151-7. PubMed ID: 1564787
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease.
    Orrego H, Kalant H, Israel Y, Blake J, Medline A, Rankin JG, Armstrong A, Kapur B.
    Gastroenterology; 1979 Jan; 76(1):105-15. PubMed ID: 758131
    [Abstract] [Full Text] [Related]

  • 15. Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease.
    Taïeb J, Mathurin P, Poynard T, Gougerot-Pocidalo MA, Chollet-Martin S.
    Lancet; 1998 Jun 27; 351(9120):1930-1. PubMed ID: 9654266
    [No Abstract] [Full Text] [Related]

  • 16. Resistance of erythrocytes to lipid peroxidation in alcoholic patients.
    Punchard NA, Senturk H, Teare JP, Thompson RP.
    Gut; 1994 Dec 27; 35(12):1753-6. PubMed ID: 7829014
    [Abstract] [Full Text] [Related]

  • 17. [Blood protein polyacrylamide gel electrophoretic data in alcoholic liver diseases].
    Samson EI, Gotsuliak OF.
    Vrach Delo; 1983 Sep 27; (9):85-8. PubMed ID: 6649581
    [No Abstract] [Full Text] [Related]

  • 18. [Alcohol and liver diseases].
    Weigand K, Kühn HA.
    Med Klin; 1980 Jul 04; 75(14):506-10. PubMed ID: 7402166
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Plasma fibronectin and alcoholic liver disease].
    Ricciardi R, Restuccia G, Chindemi G.
    Quad Sclavo Diagn; 1987 Jun 04; 23(2):153-63. PubMed ID: 3451292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.